13F-HR filed by Man Group plc
Man Group plc filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 2,022 holding rows worth $23,597,697,000.
- Accession
- 0001085146-22-003127
- Filer
- CIK 1637460
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A combination report, 3,841 entries on the cover page, a total value of $23,597,697,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $23,597,697,000 with VALUE read as thousands by filing date, 13F file number 028-18778. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerRussell Investments Group, Ltd.028-17598
- included managerAHL Partners LLP028-16037
- included managerGLG LLC028-11672
- included managerGLG Partners LP028-10979
- included managerNumeric Investors LLC028-11946
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SENIOR CONNECT ACQUISITN COR | 81723H116 | *W EXP 12/31/202 | 110,800 | $12,000 | thousands by filing date | principal |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 30,502 | $11,000 | thousands by filing date | principal |
| SPECTRUM PHARMACEUTICALS INC | 84763A108 | COM | 14,596 | $11,000 | thousands by filing date | principal |
| CURIS INC | 231269200 | COM | 11,320 | $11,000 | thousands by filing date | principal |
| MEI PHARMA INC | 55279B202 | COM NEW | 17,970 | $11,000 | thousands by filing date | principal |
| BITNILE HOLDINGS INC | 09175M101 | CMN | 39,700 | $11,000 | thousands by filing date | principal |
| Accelerate Diagnostics | 00430H102 | COM | 10,522 | $10,000 | thousands by filing date | principal |
| TREVENA INC | 89532E109 | COM | 23,125 | $10,000 | thousands by filing date | principal |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 10,812 | $10,000 | thousands by filing date | principal |
| LIBERTY TRIPADVISOR HLDGS IN | 531465102 | COM SER A | 10,598 | $8,000 | thousands by filing date | principal |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 15,299 | $8,000 | thousands by filing date | principal |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 13,247 | $8,000 | thousands by filing date | principal |
| DURECT CORP | 266605104 | COM | 16,532 | $8,000 | thousands by filing date | principal |
| BROOKLYN IMMUNOTHERAPEUTICS | 114082100 | COM | 14,824 | $8,000 | thousands by filing date | principal |
| HYRECAR INC | 44916T107 | COM | 10,685 | $7,000 | thousands by filing date | principal |
| QUOTIENT LTD | G73268107 | SHS | 28,322 | $7,000 | thousands by filing date | principal |
| ASENSUS SURGICAL INC | 04367G103 | COM | 16,008 | $6,000 | thousands by filing date | principal |
| MUSTANG BIO INC | 62818Q104 | COM | 10,622 | $6,000 | thousands by filing date | principal |
| SELECT SECTOR SPDR TR | 81369Y704 | INDL | 42 | $4,000 | thousands by filing date | principal |
| NEWAGE INC | 650194103 | COMMON STOCK | 17,578 | $4,000 | thousands by filing date | principal |
| NEBIUS GROUP N.V. | N97284108 | SHS CLASS A | 80,830 | $0 | thousands by filing date | principalValue filed as zero, left out of ratios. |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 94,740 | $0 | thousands by filing date | principalValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-22-003127 | this filing | 2022-08-15 | acceptance time not in the bulk data set |